As of 5 Nov 2026, Sotac Pharmaceuticals trades at ₹130.00. The shares rose 0.1% over the past year.
- ₹132.90
- ₹132.95
- ₹128.90
- ₹130.00
- 6K
Health check
- ReturnsModest
+0.1% over the past year.
- Price tagn/a
P/E isn’t reported.
- Growthn/a
Not enough yearly results to measure.
- Profitabilityn/a
Return ratios aren’t reported.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flagsNone found
No warning signs in the headline numbers.
Key metrics
- Market cap
- n/a
- P/E
- n/a
- Price to book
- n/a
- Dividend yield
- n/a
- ROE
- n/a
- Return on equity
- ROCE
- n/a
- Return on capital employed
- Debt to equity
- n/a
- EPS (TTM)
- n/a
- Face value ₹10
- OPM (TTM)
- n/a
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- n/a
Strengths and risks
Strengths and risks
Nothing stands out either way in the headline numbers.
About Sotac Pharmaceuticals
No company description is available.
- ISIN
- INE0O2D01012
Price range
- Avg volume (3M)
- –
- 1-year return
- plus 0.1%
- From 52-week high
- minus 2.2%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
This company doesn’t report these figures in a format we can read yet.
Forecast
Balance sheet
This company doesn’t report these figures in a format we can read yet.
Cash flow
This company doesn’t report these figures in a format we can read yet.
Shareholding pattern
NSE hasn’t returned a shareholding pattern for this company.
Major shareholders
Filings & events
News
No recent news coverage found.